ID: ALA5283993

Chembl Id: CHEMBL5283993

Max Phase: Preclinical

Molecular Formula: C34H49N7O5S

Molecular Weight: 667.88

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CN3CCN(C)CC3)nc3[nH]cnc23)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O

Standard InChI:  InChI=1S/C34H49N7O5S/c1-7-32(4)16-23(33(5)20(2)8-10-34(21(3)28(32)45)11-9-22(42)27(33)34)46-25(44)18-47-30-26-29(36-19-35-26)38-31(39-30)37-24(43)17-41-14-12-40(6)13-15-41/h7,19-21,23,27-28,45H,1,8-18H2,2-6H3,(H2,35,36,37,38,39,43)/t20-,21+,23-,27?,28+,32-,33+,34+/m1/s1

Standard InChI Key:  FDFCAEOLTKTFJJ-SIZKMEIFSA-N

Alternative Forms

  1. Parent:

    ALA5283993

    ---

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 667.88Molecular Weight (Monoisotopic): 667.3516AlogP: 3.54#Rotatable Bonds: 8
Polar Surface Area: 153.64Molecular Species: BASEHBA: 11HBD: 3
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 6.88CX Basic pKa: 9.93CX LogP: 3.39CX LogD: 3.17
Aromatic Rings: 2Heavy Atoms: 47QED Weighted: 0.16Np Likeness Score: 0.44

References

1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y..  (2023)  Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives.,  14  (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004]

Source